GLAND PHARMA
Back to Cashflow Statement
|
GLAND PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹915 Cr | ₹997 Cr | ₹364 Cr | ₹791 Cr | ₹605 Cr |
What is the latest Cash Flow from Operating Activities ratio of GLAND PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹915 Cr |
| Mar2024 | ₹997 Cr |
| Mar2023 | ₹364 Cr |
| Mar2022 | ₹791 Cr |
| Mar2021 | ₹605 Cr |
How is Cash Flow from Operating Activities of GLAND PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹915 Cr | -8.23 | |
| Mar2024 | ₹997 Cr | 173.87 | |
| Mar2023 | ₹364 Cr | -53.97 | |
| Mar2022 | ₹791 Cr | 30.72 | |
| Mar2021 | ₹605 Cr | - | |
Compare Cash Flow from Operating Activities of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹40,264.1 Cr | -3.7% | 11.7% | 31% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,179.0 Cr | -0.4% | 4.3% | 13.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹196,095.0 Cr | 0.9% | 8.9% | 8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,530.0 Cr | 0.7% | 13% | 46.5% | Stock Analytics | |
| CIPLA | ₹114,318.0 Cr | -1% | -0% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,742.1 Cr | -3.3% | -8.4% | -4.3% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | -3.7% |
11.7% |
31% |
| SENSEX | -0.6% |
-0.1% |
-6.7% |
You may also like the below Video Courses